Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Dose escalation of lenalidomide in relapsed or refractory acute leukemiasWilliam Blum, Rebecca B Klisovic, Heiko Becker, et al.
Blood|July 13, 2012
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemiaPearlly Yan, David Frankhouser, Mark Murphy, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabineWilliam Blum, Ramiro Garzon, Rebecca B Klisovic, et al.
Blood|May 9, 2012
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemiaWilliam Blum, Sebastian Schwind, Somayeh S Tarighat, et al.
Leukemia|May 22, 2021
Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeqCaner Saygin, Eileen Hu, Pu Zhang, et al.
Blood|November 17, 2021
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemiaSwagata Goswami, Rajeswaran Mani, Jessica Nunes, et al.
Blood|October 27, 2012
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemiaChristopher J Hickey, Sebastian Schwind, Hanna S Radomska, et al.
Hemasphere|February 13, 2025
Response to luspatercept can be predicted and improves overall survival in the real-life treatment of LR-MDSAngela Consagra, Luca Lanino, Najla H Al Ali, et al.
Resuscitation Plus|January 23, 2024
Route of drug administration in out-of-hospital cardiac arrest: A protocol for a randomised controlled trial (PARAMEDIC-3)Keith Couper, Chen Ji, Ranjit Lall, et al.
Nature Medicine|October 27, 2020
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master TrialAmy Burd, Ross L Levine, Amy S Ruppert, et al.
Pageof 6